Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.02 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles A. Dinarello M.D.

Chief Scientific Officer and Member of Scientific Advisory Board,Omni Bio Pharmaceutical, Inc.
AgeTotal Calculated CompensationThis person is connected to 77 board members in 9 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Charles A. Dinarello, M.D., has been Chief Scientific Officer of Omni Bio Pharmaceutical, Inc. since March 2011 and also serves as its Member of Scientific Advisory Board. Dr. Dinarello served as Acting Chief Executive Officer of Omni Bio Pharmaceutical, Inc., from since March 31, 2009 and has been its principal investigator for cellgraft rejection from October 2008. He served chief Medical Officer of Omni Bio Pharmaceutical Inc. He serves as Professor of Medicine ...

Read Full Background

Corporate Headquarters*

181 West Boardwalk
Fort Collins, Colorado 80525

United States

Phone: 970-237-5178
Fax: --

Board Members Memberships*

Director, Member of Scientific Advisory Board, Chairman of Scientific Subcommittee and Member of Nominations & Governance Committee


Unknown/Other Education
The General Hospital Corporation
Bachelor's Degree
Yale University
Yale University
Honorary Doctorate
Weizmann Institute Of Science
Honorary Doctorate
Johann Wolfgang Goethe Universität Frankfurt am Main
Honorary Doctorate
Université de Provence - Aix Marseille I
Doctorate 1997
Université de Provence - Aix Marseille I

Other Affiliations*

Annual Compensation*

Total Annual Compensation$90,000

Stock Options*

Exercisable Options2,043,000
Total Number of Options2,043,000

Total Compensation*

Total Annual Cash Compensation$90,000
Total Short Term Compensation$90,000
Total Calculated Compensation$90,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OMBP:US $0.02 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMNI BIO PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at